Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sichuan Kelun Pharmaceutical Co Ltd.

https://en.kelun.com/

Latest From Sichuan Kelun Pharmaceutical Co Ltd.

Deal Watch: Moderna, Immactics Team Up To Combine mRNA Technology With Cancer Cell Therapy

Plus deals involving Kelun Biotech, Pierre Fabre/Vertical, Novo Nordisk/Broad Institute, ABL Bio/Synaffix, Kriya/Tramontane, Palisade/Giiant and more.

Deal Watch Business Strategies

Daiichi Sankyo Comes Out Swinging At WCLC As ADCs Steal Show

The Japanese drug maker gave multiple presentations on AstraZeneca-partnered Enhertu and other deruxtecan-based ADCs. Plus Gilead presented data on Trodelvy, Amgen showed early frontline data for Lumakras, and J&J’s EGFR-directed bispecific Rybrevant showed a 50% ORR in heavily pretreated patients.

Clinical Trials Companies

Quick Listen: Scrip's Five Must-Know Things

In this week's podcast edition of Five Must-Know Things: a look at global executive compensation; Pfizer’s new myeloma approval; Merck & Co. and Kelun trump ADC breast cancer success; combo Alzheimer’s therapies in Eisai’s pipeline; and a look at the state of gene therapy.

Commercial Clinical Trials

Merck & Co’s TROP2 Partner Trumpets Phase III Success In TNBC

Merck & Co's antibody-drug conjugates pact with Kelun is progressing well and the lead candidate of the pact, the TROP2-targeting candidate codenamed SKB264/MK-2870, has significantly improved progression-free survival in triple-negative breast cancer patients in a late-stage trial in China.

Cancer Clinical Trials
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
    • Vaccines
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
      • Antibodies
    • Drug Discovery Technologies
      • Molecular Diversity
        • Natural Products
  • Other Names / Subsidiaries
    • Guangxi Kelun Pharmaceutical Co Ltd
    • Hunan Kelun Pharmaceutical Co Ltd
    • Hubei Kelun Pharmaceutical Co Ltd
    • Kelun Pharmaceutical Group
    • KLUS Pharma Inc
    • Shandong Kelun Pharmaceutical Co Ltd
    • Sichuan Kelun Pharmaceutical Research Co Ltd
    • Suzhou Kelun Pharmaceutical Research Co Ltd
    • Sichuan Xindi Pharmaceutical Chemicals Co Ltd
UsernamePublicRestriction

Register